Concepedia

Yan Li

YL

Statistics

Publications

73

Citations

4K

H-Index

33

Active since

2006

Affiliations

Xuzhou Medical College(Current)

Nantong University

Merck & Co., Inc., Rahway, NJ, USA (United States)

Chinese Academy of Medical Sciences & Peking Union Medical College

Royal Marsden NHS Foundation Trust

Yan Li is an author at Xuzhou Medical College specializing in medicine, cell biology, and pharmacology.

ORCID

Top concepts

Publications per year

2006–2024

73

Publications

73

First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors

Timothy A. Yap, Yan Li, Amita Patnaik et al. · Journal of Clinical Oncology · 2011 · 539 citations

AMPylation of Rho GTPases by <i>Vibrio</i> VopS Disrupts Effector Binding and Downstream Signaling

Melanie L. Yarbrough, Yan Li, Lisa N. Kinch et al. · Science · 2008 · 357 citations

CRISPR Reveals a Distal Super-Enhancer Required for Sox2 Expression in Mouse Embryonic Stem Cells

Yan Li, Chloe M. Rivera, Haruhiko Ishii et al. · PLoS ONE · 2014 · 212 citations · Full text

, , +20

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

L. Rhoda Molife, Yan Li, Joanna Vitfell-Rasmussen et al. · Journal of Hematology & Oncology · 2014 · 189 citations · Full text

Elevating CXCR7 Improves Angiogenic Function of EPCs via Akt/GSK-3β/Fyn-Mediated Nrf2 Activation in Diabetic Limb Ischemia

Xiaozhen Dai, Xiaoqing Yan, Jun Zeng et al. · Circulation Research · 2017 · 166 citations · Full text

1–5 of 73